1 Study Coverage 1.1 Carboplatin Injection Product Introduction 1.2 Market by Type 1.2.1 Global Carboplatin Injection Market Size Growth Rate by Type 1.2.2 10ml:50mg 1.2.3 10ml:100mg 1.2.4 Other 1.3 Market by Application 1.3.1 Global Carboplatin Injection Market Size Growth Rate by Application 1.3.2 Ovarian Cancer 1.3.3 Breast Cancer 1.3.4 SCLC 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Carboplatin Injection Market Size, Estimates and Forecasts 2.1.1 Global Carboplatin Injection Revenue 2016-2027 2.1.2 Global Carboplatin Injection Sales 2016-2027 2.2 Global Carboplatin Injection, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Carboplatin Injection Historical Market Size by Region (2016-2021) 2.3.1 Global Carboplatin Injection Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Carboplatin Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Carboplatin Injection Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Carboplatin Injection Sales Forecast by Region (2022-2027) 2.4.2 Global Carboplatin Injection Revenue Forecast by Region (2022-2027) 3 Global Carboplatin Injection Competitor Landscape by Players 3.1 Global Top Carboplatin Injection Manufacturers by Sales 3.1.1 Global Carboplatin Injection Sales by Manufacturer (2016-2021) 3.1.2 Global Carboplatin Injection Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Carboplatin Injection Manufacturers by Revenue 3.2.1 Key Carboplatin Injection Manufacturers Covered: Ranking by Revenue 3.2.2 Global Carboplatin Injection Revenue by Manufacturers (2016-2021) 3.2.3 Global Carboplatin Injection Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Carboplatin Injection Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Carboplatin Injection Revenue in 2020 3.2.6 Global Carboplatin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Carboplatin Injection Price by Manufacturers 3.4 Global Carboplatin Injection Manufacturing Base Distribution, Product Types 3.4.1 Carboplatin Injection Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Carboplatin Injection Product Type 3.4.3 Date of International Manufacturers Enter into Carboplatin Injection Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Carboplatin Injection Market Size by Type (2016-2021) 4.1.1 Global Carboplatin Injection Sales by Type (2016-2021) 4.1.2 Global Carboplatin Injection Revenue by Type (2016-2021) 4.1.3 Carboplatin Injection Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Carboplatin Injection Market Size Forecast by Type (2022-2027) 4.2.1 Global Carboplatin Injection Sales Forecast by Type (2022-2027) 4.2.2 Global Carboplatin Injection Revenue Forecast by Type (2022-2027) 4.2.3 Carboplatin Injection Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Carboplatin Injection Market Size by Application (2016-2021) 5.1.1 Global Carboplatin Injection Sales by Application (2016-2021) 5.1.2 Global Carboplatin Injection Revenue by Application (2016-2021) 5.1.3 Carboplatin Injection Price by Application (2016-2021) 5.2 Carboplatin Injection Market Size Forecast by Application (2022-2027) 5.2.1 Global Carboplatin Injection Sales Forecast by Application (2022-2027) 5.2.2 Global Carboplatin Injection Revenue Forecast by Application (2022-2027) 5.2.3 Global Carboplatin Injection Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Carboplatin Injection Market Size YoY Growth 2016-2027 6.1.1 United States Carboplatin Injection Sales YoY Growth 2016-2027 6.1.2 United States Carboplatin Injection Revenue YoY Growth 2016-2027 6.1.3 United States Carboplatin Injection Market Share in Global Market 2016-2027 6.2 United States Carboplatin Injection Market Size by Players (International and Local Players) 6.2.1 United States Top Carboplatin Injection Players by Sales (2016-2021) 6.2.2 United States Top Carboplatin Injection Players by Revenue (2016-2021) 6.3 United States Carboplatin Injection Historic Market Review by Type (2016-2021) 6.3.1 United States Carboplatin Injection Sales Market Share by Type (2016-2021) 6.3.2 United States Carboplatin Injection Revenue Market Share by Type (2016-2021) 6.3.3 United States Carboplatin Injection Price by Type (2016-2021) 6.4 United States Carboplatin Injection Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Carboplatin Injection Sales Forecast by Type (2022-2027) 6.4.2 United States Carboplatin Injection Revenue Forecast by Type (2022-2027) 6.4.3 United States Carboplatin Injection Price Forecast by Type (2022-2027) 6.5 United States Carboplatin Injection Historic Market Review by Application (2016-2021) 6.5.1 United States Carboplatin Injection Sales Market Share by Application (2016-2021) 6.5.2 United States Carboplatin Injection Revenue Market Share by Application (2016-2021) 6.5.3 United States Carboplatin Injection Price by Application (2016-2021) 6.6 United States Carboplatin Injection Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Carboplatin Injection Sales Forecast by Application (2022-2027) 6.6.2 United States Carboplatin Injection Revenue Forecast by Application (2022-2027) 6.6.3 United States Carboplatin Injection Price Forecast by Application (2022-2027) 7 North America 7.1 North America Carboplatin Injection Market Size YoY Growth 2016-2027 7.2 North America Carboplatin Injection Market Facts & Figures by Country 7.2.1 North America Carboplatin Injection Sales by Country (2016-2021) 7.2.2 North America Carboplatin Injection Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Carboplatin Injection Market Size YoY Growth 2016-2027 8.2 Asia Pacific Carboplatin Injection Market Facts & Figures by Region 8.2.1 Asia Pacific Carboplatin Injection Sales by Region (2016-2021) 8.2.2 Asia Pacific Carboplatin Injection Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Carboplatin Injection Market Size YoY Growth 2016-2027 9.2 Europe Carboplatin Injection Market Facts & Figures by Country 9.2.1 Europe Carboplatin Injection Sales by Country (2016-2021) 9.2.2 Europe Carboplatin Injection Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Carboplatin Injection Market Size YoY Growth 2016-2027 10.2 Latin America Carboplatin Injection Market Facts & Figures by Country 10.2.1 Latin America Carboplatin Injection Sales by Country (2016-2021) 10.2.2 Latin America Carboplatin Injection Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Carboplatin Injection Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Carboplatin Injection Market Facts & Figures by Country 11.2.1 Middle East and Africa Carboplatin Injection Sales by Country (2016-2021) 11.2.2 Middle East and Africa Carboplatin Injection Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Hospira(Pfizer) 12.1.1 Hospira(Pfizer) Corporation Information 12.1.2 Hospira(Pfizer) Description and Business Overview 12.1.3 Hospira(Pfizer) Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Hospira(Pfizer) Carboplatin Injection Products Offered 12.1.5 Hospira(Pfizer) Recent Development 12.2 Bristol-Myers Squibb SA 12.2.1 Bristol-Myers Squibb SA Corporation Information 12.2.2 Bristol-Myers Squibb SA Description and Business Overview 12.2.3 Bristol-Myers Squibb SA Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Bristol-Myers Squibb SA Carboplatin Injection Products Offered 12.2.5 Bristol-Myers Squibb SA Recent Development 12.3 Teva 12.3.1 Teva Corporation Information 12.3.2 Teva Description and Business Overview 12.3.3 Teva Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Teva Carboplatin Injection Products Offered 12.3.5 Teva Recent Development 12.4 Mylan 12.4.1 Mylan Corporation Information 12.4.2 Mylan Description and Business Overview 12.4.3 Mylan Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Mylan Carboplatin Injection Products Offered 12.4.5 Mylan Recent Development 12.5 Taj Pharmaceuticals 12.5.1 Taj Pharmaceuticals Corporation Information 12.5.2 Taj Pharmaceuticals Description and Business Overview 12.5.3 Taj Pharmaceuticals Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Taj Pharmaceuticals Carboplatin Injection Products Offered 12.5.5 Taj Pharmaceuticals Recent Development 12.6 Fresenius Kabi 12.6.1 Fresenius Kabi Corporation Information 12.6.2 Fresenius Kabi Description and Business Overview 12.6.3 Fresenius Kabi Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Fresenius Kabi Carboplatin Injection Products Offered 12.6.5 Fresenius Kabi Recent Development 12.7 Qilu Pharmaceutical 12.7.1 Qilu Pharmaceutical Corporation Information 12.7.2 Qilu Pharmaceutical Description and Business Overview 12.7.3 Qilu Pharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Qilu Pharmaceutical Carboplatin Injection Products Offered 12.7.5 Qilu Pharmaceutical Recent Development 12.8 Cisen Pharmaceutical 12.8.1 Cisen Pharmaceutical Corporation Information 12.8.2 Cisen Pharmaceutical Description and Business Overview 12.8.3 Cisen Pharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Cisen Pharmaceutical Carboplatin Injection Products Offered 12.8.5 Cisen Pharmaceutical Recent Development 12.9 Yunnan Phytopharmaceutical 12.9.1 Yunnan Phytopharmaceutical Corporation Information 12.9.2 Yunnan Phytopharmaceutical Description and Business Overview 12.9.3 Yunnan Phytopharmaceutical Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Yunnan Phytopharmaceutical Carboplatin Injection Products Offered 12.9.5 Yunnan Phytopharmaceutical Recent Development 12.10 Hisun 12.10.1 Hisun Corporation Information 12.10.2 Hisun Description and Business Overview 12.10.3 Hisun Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Hisun Carboplatin Injection Products Offered 12.10.5 Hisun Recent Development 12.11 Hospira(Pfizer) 12.11.1 Hospira(Pfizer) Corporation Information 12.11.2 Hospira(Pfizer) Description and Business Overview 12.11.3 Hospira(Pfizer) Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Hospira(Pfizer) Carboplatin Injection Products Offered 12.11.5 Hospira(Pfizer) Recent Development 12.12 Yangzijiang Group 12.12.1 Yangzijiang Group Corporation Information 12.12.2 Yangzijiang Group Description and Business Overview 12.12.3 Yangzijiang Group Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Yangzijiang Group Products Offered 12.12.5 Yangzijiang Group Recent Development 12.13 Shandong Ruiying 12.13.1 Shandong Ruiying Corporation Information 12.13.2 Shandong Ruiying Description and Business Overview 12.13.3 Shandong Ruiying Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Shandong Ruiying Products Offered 12.13.5 Shandong Ruiying Recent Development 12.14 Shanghai Acebright Pharmaceuticals 12.14.1 Shanghai Acebright Pharmaceuticals Corporation Information 12.14.2 Shanghai Acebright Pharmaceuticals Description and Business Overview 12.14.3 Shanghai Acebright Pharmaceuticals Carboplatin Injection Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Shanghai Acebright Pharmaceuticals Products Offered 12.14.5 Shanghai Acebright Pharmaceuticals Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Carboplatin Injection Industry Trends 13.2 Carboplatin Injection Market Drivers 13.3 Carboplatin Injection Market Challenges 13.4 Carboplatin Injection Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Carboplatin Injection Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Carboplatin Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 10ml:50mg Table 3. Major Manufacturers of 10ml:100mg Table 4. Major Manufacturers of Other Table 5. Global Carboplatin Injection Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Carboplatin Injection Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Carboplatin Injection Sales by Regions (2016-2021) & (K Units) Table 8. Global Carboplatin Injection Sales Market Share by Regions (2016-2021) Table 9. Global Carboplatin Injection Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Carboplatin Injection Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Carboplatin Injection Sales Market Share Forecast by Region (2022-2027) Table 12. Global Carboplatin Injection Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Carboplatin Injection Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Carboplatin Injection Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Carboplatin Injection Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Carboplatin Injection Manufacturers by Revenue (US$ Million) in 2020 Table 17. Carboplatin Injection Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Carboplatin Injection Revenue Share by Manufacturers (2016-2021) Table 19. Global Carboplatin Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Carboplatin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carboplatin Injection as of 2020) Table 21. Key Manufacturers Carboplatin Injection Price (2016-2021) (US$/Unit) Table 22. Carboplatin Injection Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Carboplatin Injection Product Type Table 24. Date of International Manufacturers Enter into Carboplatin Injection Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Carboplatin Injection Sales by Type (2016-2021) (K Units) Table 27. Global Carboplatin Injection Sales Share by Type (2016-2021) Table 28. Global Carboplatin Injection Revenue by Type (2016-2021) (US$ Million) Table 29. Global Carboplatin Injection Revenue Share by Type (2016-2021) Table 30. Carboplatin Injection Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Carboplatin Injection Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Carboplatin Injection Sales Market Share Forecast by Type (2022-2027) Table 33. Global Carboplatin Injection Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Carboplatin Injection Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Carboplatin Injection Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Carboplatin Injection Sales by Application (2016-2021) (K Units) Table 37. Global Carboplatin Injection Sales Share by Application (2016-2021) Table 38. Global Carboplatin Injection Revenue by Application (2016-2021) (US$ Million) Table 39. Global Carboplatin Injection Revenue Share by Application (2016-2021) Table 40. Carboplatin Injection Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Carboplatin Injection Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Carboplatin Injection Sales Market Share Forecast by Application (2022-2027) Table 43. Global Carboplatin Injection Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Carboplatin Injection Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Carboplatin Injection Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. United States Carboplatin Injection Sales (K Units) of Key Companies (2016-2021) Table 47. United States Carboplatin Injection Sales Share by Company (2016-2021) Table 48. United States Carboplatin Injection Revenue (US$ Million) by Company (2016-2021) Table 49. United States Carboplatin Injection Revenue Share by Company (2016-2021) Table 50. United States Carboplatin Injection Sales (K Units) by Type (2016-2021) Table 51. United States Carboplatin Injection Sales Share by Type (2016-2021) Table 52. United States Carboplatin Injection Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. United States Carboplatin Injection Price (US$/Unit) by Type (2016-2021) Table 54. United States Carboplatin Injection Sales (K Units) by Type (2022-2027) Table 55. United States Carboplatin Injection Sales Share by Type (2022-2027) Table 56. United States Carboplatin Injection Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. United States Carboplatin Injection Revenue Share by Type (2022-2027) Table 58. United States Carboplatin Injection Price (US$/Unit) by Type (2022-2027) Table 59. United States Carboplatin Injection Sales (K Units) by Application (2016-2021) Table 60. United States Carboplatin Injection Sales Share by Application (2016-2021) Table 61. United States Carboplatin Injection Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. United States Carboplatin Injection Price (US$/Unit) by Application (2016-2021) Table 63. United States Carboplatin Injection Sales (K Units) by Application (2022-2027) Table 64. United States Carboplatin Injection Sales Share by Application (2022-2027) Table 65. United States Carboplatin Injection Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. United States Carboplatin Injection Revenue Share by Application (2022-2027) Table 67. United States Carboplatin Injection Price (US$/Unit) by Application (2022-2027) Table 68. North America Carboplatin Injection Sales by Country (2016-2021) & (K Units) Table 69. North America Carboplatin Injection Sales Market Share by Country (2016-2021) Table 70. North America Carboplatin Injection Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Carboplatin Injection Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Carboplatin Injection Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Carboplatin Injection Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Carboplatin Injection Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Carboplatin Injection Revenue Market Share by Region (2016-2021) Table 76. Europe Carboplatin Injection Sales by Country (2016-2021) & (K Units) Table 77. Europe Carboplatin Injection Sales Market Share by Country (2016-2021) Table 78. Europe Carboplatin Injection Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Carboplatin Injection Revenue Market Share by Country (2016-2021) Table 80. Latin America Carboplatin Injection Sales by Country (2016-2021) & (K Units) Table 81. Latin America Carboplatin Injection Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Carboplatin Injection Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Carboplatin Injection Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Carboplatin Injection Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Carboplatin Injection Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Carboplatin Injection Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Carboplatin Injection Revenue Market Share by Country (2016-2021) Table 88. Hospira(Pfizer) Corporation Information Table 89. Hospira(Pfizer) Description and Business Overview Table 90. Hospira(Pfizer) Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Hospira(Pfizer) Carboplatin Injection Product Table 92. Hospira(Pfizer) Recent Development Table 93. Bristol-Myers Squibb SA Corporation Information Table 94. Bristol-Myers Squibb SA Description and Business Overview Table 95. Bristol-Myers Squibb SA Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Bristol-Myers Squibb SA Product Table 97. Bristol-Myers Squibb SA Recent Development Table 98. Teva Corporation Information Table 99. Teva Description and Business Overview Table 100. Teva Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Teva Product Table 102. Teva Recent Development Table 103. Mylan Corporation Information Table 104. Mylan Description and Business Overview Table 105. Mylan Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Mylan Product Table 107. Mylan Recent Development Table 108. Taj Pharmaceuticals Corporation Information Table 109. Taj Pharmaceuticals Description and Business Overview Table 110. Taj Pharmaceuticals Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Taj Pharmaceuticals Product Table 112. Taj Pharmaceuticals Recent Development Table 113. Fresenius Kabi Corporation Information Table 114. Fresenius Kabi Description and Business Overview Table 115. Fresenius Kabi Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Fresenius Kabi Product Table 117. Fresenius Kabi Recent Development Table 118. Qilu Pharmaceutical Corporation Information Table 119. Qilu Pharmaceutical Description and Business Overview Table 120. Qilu Pharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Qilu Pharmaceutical Product Table 122. Qilu Pharmaceutical Recent Development Table 123. Cisen Pharmaceutical Corporation Information Table 124. Cisen Pharmaceutical Description and Business Overview Table 125. Cisen Pharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. Cisen Pharmaceutical Product Table 127. Cisen Pharmaceutical Recent Development Table 128. Yunnan Phytopharmaceutical Corporation Information Table 129. Yunnan Phytopharmaceutical Description and Business Overview Table 130. Yunnan Phytopharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Yunnan Phytopharmaceutical Product Table 132. Yunnan Phytopharmaceutical Recent Development Table 133. Hisun Corporation Information Table 134. Hisun Description and Business Overview Table 135. Hisun Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. Hisun Product Table 137. Hisun Recent Development Table 138. Jiangsu Lianhuan Pharmaceutical Corporation Information Table 139. Jiangsu Lianhuan Pharmaceutical Description and Business Overview Table 140. Jiangsu Lianhuan Pharmaceutical Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 141. Jiangsu Lianhuan Pharmaceutical Product Table 142. Jiangsu Lianhuan Pharmaceutical Recent Development Table 143. Yangzijiang Group Corporation Information Table 144. Yangzijiang Group Description and Business Overview Table 145. Yangzijiang Group Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 146. Yangzijiang Group Product Table 147. Yangzijiang Group Recent Development Table 148. Shandong Ruiying Corporation Information Table 149. Shandong Ruiying Description and Business Overview Table 150. Shandong Ruiying Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 151. Shandong Ruiying Product Table 152. Shandong Ruiying Recent Development Table 153. Shanghai Acebright Pharmaceuticals Corporation Information Table 154. Shanghai Acebright Pharmaceuticals Description and Business Overview Table 155. Shanghai Acebright Pharmaceuticals Carboplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 156. Shanghai Acebright Pharmaceuticals Product Table 157. Shanghai Acebright Pharmaceuticals Recent Development Table 158. Carboplatin Injection Market Trends Table 159. Carboplatin Injection Market Drivers Table 160. Carboplatin Injection Market Challenges Table 161. Carboplatin Injection Market Restraints Table 162. Carboplatin Injection Customers List Table 163. Carboplatin Injection Distributors List Table 164. Research Programs/Design for This Report Table 165. Key Data Information from Secondary Sources Table 166. Key Data Information from Primary Sources List of Figures Figure 1. Carboplatin Injection Product Picture Figure 2. Global Carboplatin Injection Sales Market Share by Type in 2020 & 2027 Figure 3. 10ml:50mg Product Picture Figure 4. 10ml:100mg Product Picture Figure 5. Other Product Picture Figure 6. Global Carboplatin Injection Sales Market Share by Application in 2020 & 2027 Figure 7. Ovarian Cancer Figure 8. Breast Cancer Figure 9. SCLC Figure 10. Other Figure 11. Carboplatin Injection Report Years Considered Figure 12. Global Carboplatin Injection Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Carboplatin Injection Market Size 2016-2027 (US$ Million) Figure 14. Global Carboplatin Injection Sales 2016-2027 (K Units) Figure 15. Global Carboplatin Injection Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Carboplatin Injection Sales Market Share by Region (2016-2021) Figure 17. Global Carboplatin Injection Sales Market Share by Region in 2020 Figure 18. Global Carboplatin Injection Revenue Market Share by Region (2016-2021) Figure 19. Global Carboplatin Injection Revenue Market Share by Region in 2020 Figure 20. Global Carboplatin Injection Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Carboplatin Injection Revenue in 2020 Figure 22. Carboplatin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Carboplatin Injection Sales Market Share by Type (2016-2021) Figure 24. Global Carboplatin Injection Sales Market Share by Type in 2020 Figure 25. Global Carboplatin Injection Revenue Market Share by Type (2016-2021) Figure 26. Global Carboplatin Injection Revenue Market Share by Type in 2020 Figure 27. Global Carboplatin Injection Sales Market Share by Application (2016-2021) Figure 28. Global Carboplatin Injection Sales Market Share by Application in 2020 Figure 29. Global Carboplatin Injection Revenue Market Share by Application (2016-2021) Figure 30. Global Carboplatin Injection Revenue Market Share by Application in 2020 Figure 31. United States Carboplatin Injection Sales Growth Rate 2016-2027 (K Units) Figure 32. United States Carboplatin Injection Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. United States Carboplatin Injection Market Share in Global Market 2016-2027 Figure 34. United States 5 and 10 Largest Carboplatin Injection Players Market Share by Revenue in Carboplatin Injection in 2020 Figure 35. United States Carboplatin Injection Revenue Share by Type (2016-2021) Figure 36. United States Carboplatin Injection Revenue Growth Rate by Type in 2016 & 2020 Figure 37. United States Carboplatin Injection Revenue Share by Application (2016-2021) Figure 38. United States Carboplatin Injection Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Carboplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 40. North America Carboplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Carboplatin Injection Sales Market Share by Country in 2020 Figure 42. North America Carboplatin Injection Revenue Market Share by Country in 2020 Figure 43. United States Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 44. United States Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 46. Canada Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Carboplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 48. Europe Carboplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Carboplatin Injection Sales Market Share by Country in 2020 Figure 50. Europe Carboplatin Injection Revenue Market Share by Country in 2020 Figure 51. Germany Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 52. Germany Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 54. France Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 56. U.K. Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 58. Italy Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 60. Russia Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Carboplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 62. Asia Pacific Carboplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Carboplatin Injection Sales Market Share by Region in 2020 Figure 64. Asia Pacific Carboplatin Injection Revenue Market Share by Region in 2020 Figure 65. China Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 66. China Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 68. Japan Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 70. South Korea Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 72. India Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 74. Australia Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. China Taiwan Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 76. China Taiwan Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 78. Indonesia Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 80. Thailand Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 82. Malaysia Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Latin America Carboplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 84. Latin America Carboplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 85. Latin America Carboplatin Injection Sales Market Share by Country in 2020 Figure 86. Latin America Carboplatin Injection Revenue Market Share by Country in 2020 Figure 87. Mexico Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 88. Mexico Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 89. Brazil Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 90. Brazil Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Argentina Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 92. Argentina Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Middle East and Africa Carboplatin Injection Sales Growth Rate 2016-2021 (K Units) Figure 94. Middle East and Africa Carboplatin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 95. Middle East and Africa Carboplatin Injection Sales Market Share by Country in 2020 Figure 96. Middle East and Africa Carboplatin Injection Revenue Market Share by Country in 2020 Figure 97. Turkey Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 98. Turkey Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 99. Saudi Arabia Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 100. Saudi Arabia Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. UAE Carboplatin Injection Sales Growth Rate (2016-2021) (K Units) Figure 102. UAE Carboplatin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Carboplatin Injection Value Chain Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Bottom-up and Top-down Approaches for This Report Figure 107. Data Triangulation Figure 108. Key Executives Interviewed

Hospira(Pfizer) Bristol-Myers Squibb SA Teva Mylan Taj Pharmaceuticals Fresenius Kabi Qilu Pharmaceutical Cisen Pharmaceutical Yunnan Phytopharmaceutical Hisun Jiangsu Lianhuan Pharmaceutical Yangzijiang Group Shandong Ruiying Shanghai Acebright Pharmaceuticals